MedPath

Fluorodopa

These highlights do not include all the information needed to use FLUORODOPA F 18 Injection safely and effectively. See full prescribing information for FLUORODOPA F 18 Injection. FLUORODOPA F 18 Injection, for intravenous useInitial U.S. Approval: 2019

Approved
Approval ID

262503e7-de09-4b42-9963-ec00cbc7c35c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 12, 2019

Manufacturers
FDA

THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH

DUNS: 110565913

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluorodopa F18

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13267-345
Application NumberNDA200655
Product Classification
M
Marketing Category
C73594
G
Generic Name
Fluorodopa F18
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 16, 2019
FDA Product Classification

INGREDIENTS (1)

FLUORODOPA F-18Active
Quantity: 8.33 mCi in 1 mL
Code: 2C598205QX
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fluorodopa - FDA Drug Approval Details